Asep Medical Holdings Stock Net Income
| SEPSF Stock | USD 0.01 0.00 0.00% |
As of the 13th of February 2026, Asep Medical shows the mean deviation of 2.9, and Risk Adjusted Performance of (0.09). In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Asep Medical, as well as the relationship between them. Please confirm Asep Medical Holdings coefficient of variation and maximum drawdown to decide if Asep Medical Holdings is priced correctly, providing market reflects its regular price of 0.0109 per share. As Asep Medical Holdings appears to be a penny stock we also recommend to validate its information ratio numbers.
Asep Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Asep Medical's valuation are provided below:Asep Medical Holdings does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Asep |
Asep Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Asep Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Asep Medical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Asep Medical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Asep Medical Holdings or generate 0.0% return on investment in Asep Medical over 90 days. Asep Medical is related to or competes with Rocket Pharmaceuticals, Aura Biosciences, Annexon, Solid Biosciences, Larimar Therapeutics, Altimmune, and Autolus Therapeutics. Asep Medical Holdings Inc., through its subsidiary, ASEP Medical Inc More
Asep Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Asep Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Asep Medical Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 97.21 |
Asep Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Asep Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Asep Medical's standard deviation. In reality, there are many statistical measures that can use Asep Medical historical prices to predict the future Asep Medical's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.48) | |||
| Total Risk Alpha | (2.53) | |||
| Treynor Ratio | 30.7 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Asep Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Asep Medical February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 30.71 | |||
| Mean Deviation | 2.9 | |||
| Coefficient Of Variation | (812.40) | |||
| Standard Deviation | 11.97 | |||
| Variance | 143.16 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (1.48) | |||
| Total Risk Alpha | (2.53) | |||
| Treynor Ratio | 30.7 | |||
| Maximum Drawdown | 97.21 | |||
| Skewness | (8.12) | |||
| Kurtosis | 66.0 |
Asep Medical Holdings Backtested Returns
Asep Medical Holdings secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of standard deviation over the last 3 months. Asep Medical Holdings exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Asep Medical's risk adjusted performance of (0.09), and Mean Deviation of 2.9 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0483, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Asep Medical are expected to decrease at a much lower rate. During the bear market, Asep Medical is likely to outperform the market. At this point, Asep Medical Holdings has a negative expected return of -1.59%. Please make sure to confirm Asep Medical's coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day typical price , to decide if Asep Medical Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Asep Medical Holdings has no correlation between past and present. Overlapping area represents the amount of predictability between Asep Medical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Asep Medical Holdings price movement. The serial correlation of 0.0 indicates that just 0.0% of current Asep Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Asep Medical Holdings reported net income of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.0% higher than that of the company.
Asep Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Asep Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Asep Medical could also be used in its relative valuation, which is a method of valuing Asep Medical by comparing valuation metrics of similar companies.Asep Medical is currently under evaluation in net income category among its peers.
Asep Fundamentals
| Current Valuation | 16.86 M | |||
| Shares Outstanding | 62.13 M | |||
| Shares Owned By Insiders | 5.03 % | |||
| Price To Book | 0.76 X | |||
| Market Capitalization | 24.85 M |
About Asep Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Asep Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Asep Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Asep Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Asep Pink Sheet
Asep Medical financial ratios help investors to determine whether Asep Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Asep with respect to the benefits of owning Asep Medical security.